Trump imposes 50% tariffs on copper, says pharma tariffs could reach 200%
Trump said he is planning to impose tariffs on imported semiconductors and pharmaceuticals, with medicine tariffs potentially reaching 200 per cent. However, he said drugmakers would be given about a year “to get their act together”.
US President Donald Trump on Tuesday announced 50 per cent tariffs on copper, after having implemented similar duties on steel and aluminium. He added that tariffs on pharmaceuticals could rise to 200 per cent after a year.
This is significant for India, which exported $2 billion worth of copper and copper products globally in 2024–25, with the US accounting for $360 million, or 17 per cent, of that total. The US is also India’s largest overseas market for pharmaceuticals. Drug exports to the US rose to $9.8 billion in FY25, up 21 per cent from $8.1 billion the previous year, and now account for 40 per cent of India’s total pharma exports.
Trump said he is planning to impose tariffs on imported semiconductors and pharmaceuticals, with medicine tariffs potentially reaching 200 per cent. However, he said drugmakers would be given about a year “to get their act together”.
“We’re going to give people about a year, a year and a half to come in and, after that, they’re going to be tariffed,” Trump told reporters during a Cabinet meeting at the White House.
Reiterating his threat of a 10 per cent tariff on BRICS, Trump said the bloc was “not a serious grouping” but acknowledged that it is challenging the US dollar. “It’s alright if you want to challenge the dollar. But they will have to pay the tariffs. I don’t think they want that,” he said.
“If they have to bring the pharmaceuticals into the country… they’re going to be tariffed at a very, very high rate, like 200 per cent. We’ll give them a certain period of time to get their act together,” he said.
“We’re going to be announcing pharmaceuticals, chips, and a couple of other things — you know, big ones,” Trump added, while unveiling the new tariff on copper.
Story continues below this ad
Trade data showed that the US is India’s third-largest copper export market, after Saudi Arabia (26 per cent) and China (18 per cent). However, given copper’s status as a critical mineral and its extensive use across infrastructure, energy and manufacturing, India’s domestic industry is likely to absorb any decline in US demand resulting from the proposed tariffs.
A 200 per cent tariff on pharmaceutical exports could severely impact demand, especially as India’s generics industry plays a key role in supplying affordable medicines to the US healthcare system.
Reiterating his threat of a 10 per cent tariff on BRICS, Trump said the bloc was “not a serious grouping” but acknowledged that it is challenging the US dollar. “It’s alright if you want to challenge the dollar. But they will have to pay the tariffs. I don’t think they want that,” he said.
Aggam Walia is a Correspondent at The Indian Express, reporting on power, renewables, and mining. His work unpacks intricate ties between corporations, government, and policy, often relying on documents sourced via the RTI Act. Off the beat, he enjoys running through Delhi's parks and forests, walking to places, and cooking pasta. ... Read More
Ravi Dutta Mishra is a Principal Correspondent with The Indian Express, specializing in economic policy and financial regulations. With over five years of experience in business journalism, he provides critical coverage of the frameworks that govern India's commercial landscape.
Expertise & Focus Areas: Mishra’s reporting concentrates on the intersection of government policy and market operations. His core beats include:
Trade & Commerce: Analysis of India's import-export trends, trade agreements, and commercial policies.
Banking & Finance: Covering regulatory changes and policy decisions affecting the banking sector.
Professional Experience: Prior to joining The Indian Express, Mishra built a robust portfolio working with some of India's leading financial news organizations. His background includes tenures at:
Mint
CNBC-TV18
This diverse experience across both print and broadcast media has equipped him with a holistic understanding of financial storytelling and news cycles.
Find all stories by Ravi Dutta Mishra here ... Read More